169 related articles for article (PubMed ID: 12929634)
1. Pyrimethamine analogs as strong inhibitors of double and quadruple mutants of dihydrofolate reductase in human malaria parasites.
Sardarian A; Douglas KT; Read M; Sims PF; Hyde JE; Chitnumsub P; Sirawaraporn R; Sirawaraporn W
Org Biomol Chem; 2003 Mar; 1(6):960-4. PubMed ID: 12929634
[TBL] [Abstract][Full Text] [Related]
2. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.
Kamchonwongpaisan S; Quarrell R; Charoensetakul N; Ponsinet R; Vilaivan T; Vanichtanankul J; Tarnchompoo B; Sirawaraporn W; Lowe G; Yuthavong Y
J Med Chem; 2004 Jan; 47(3):673-80. PubMed ID: 14736247
[TBL] [Abstract][Full Text] [Related]
4. Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum.
Tarnchompoo B; Sirichaiwat C; Phupong W; Intaraudom C; Sirawaraporn W; Kamchonwongpaisan S; Vanichtanankul J; Thebtaranonth Y; Yuthavong Y
J Med Chem; 2002 Mar; 45(6):1244-52. PubMed ID: 11881993
[TBL] [Abstract][Full Text] [Related]
5. Novel alleles of the Plasmodium falciparum dhfr highly resistant to pyrimethamine and chlorcycloguanil, but not WR99210.
Hankins EG; Warhurst DC; Sibley CH
Mol Biochem Parasitol; 2001 Sep; 117(1):91-102. PubMed ID: 11551635
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the activities of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays.
Bunyarataphan S; Leartsakulpanich U; Taweechai S; Tarnchompoo B; Kamchonwongpaisan S; Yuthavong Y
Antimicrob Agents Chemother; 2006 Nov; 50(11):3631-7. PubMed ID: 16954316
[TBL] [Abstract][Full Text] [Related]
8. Flexible diaminodihydrotriazine inhibitors of Plasmodium falciparum dihydrofolate reductase: Binding strengths, modes of binding and their antimalarial activities.
Kamchonwongpaisan S; Charoensetakul N; Srisuwannaket C; Taweechai S; Rattanajak R; Vanichtanankul J; Vitsupakorn D; Arwon U; Thongpanchang C; Tarnchompoo B; Vilaivan T; Yuthavong Y
Eur J Med Chem; 2020 Jun; 195():112263. PubMed ID: 32294614
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics of interactions between rigid and flexible antifolates and dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium falciparum.
Mokmak W; Chunsrivirot S; Hannongbua S; Yuthavong Y; Tongsima S; Kamchonwongpaisan S
Chem Biol Drug Des; 2014 Oct; 84(4):450-61. PubMed ID: 24716467
[TBL] [Abstract][Full Text] [Related]
10. Combined spatial limitation around residues 16 and 108 of Plasmodium falciparum dihydrofolate reductase explains resistance to cycloguanil.
Vanichtanankul J; Taweechai S; Uttamapinant C; Chitnumsub P; Vilaivan T; Yuthavong Y; Kamchonwongpaisan S
Antimicrob Agents Chemother; 2012 Jul; 56(7):3928-35. PubMed ID: 22526319
[TBL] [Abstract][Full Text] [Related]
11. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya.
Khan B; Omar S; Kanyara JN; Warren-Perry M; Nyalwidhe J; Peterson DS; Wellems T; Kaniaru S; Gitonga J; Mulaa FJ; Koech DK
Trans R Soc Trop Med Hyg; 1997; 91(4):456-60. PubMed ID: 9373654
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
Hekmat-Nejad M; Rathod PK
Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
14. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
[TBL] [Abstract][Full Text] [Related]
15. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum.
Wooden JM; Hartwell LH; Vasquez B; Sibley CH
Mol Biochem Parasitol; 1997 Mar; 85(1):25-40. PubMed ID: 9108546
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of dihydrofolate reductase from Plasmodium falciparum: analysis in Saccharomyces cerevisiae of triple mutant alleles resistant to pyrimethamine or WR99210.
Ferlan JT; Mookherjee S; Okezie IN; Fulgence L; Sibley CH
Mol Biochem Parasitol; 2001 Mar; 113(1):139-50. PubMed ID: 11254962
[TBL] [Abstract][Full Text] [Related]
17. Malaria antifolate resistance with contrasting Plasmodium falciparum dihydrofolate reductase (DHFR) polymorphisms in humans and Anopheles mosquitoes.
Mharakurwa S; Kumwenda T; Mkulama MA; Musapa M; Chishimba S; Shiff CJ; Sullivan DJ; Thuma PE; Liu K; Agre P
Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18796-801. PubMed ID: 22065788
[TBL] [Abstract][Full Text] [Related]
18. Transgenic pyrimethamine-resistant plasmodium falciparum reveals transmission-blocking potency of P218, a novel antifolate candidate drug.
Posayapisit N; Pengon J; Prommana P; Shoram M; Yuthavong Y; Uthaipibull C; Kamchonwongpaisan S; Jupatanakul N
Int J Parasitol; 2021 Jul; 51(8):635-642. PubMed ID: 33713651
[TBL] [Abstract][Full Text] [Related]
19. Novel antifolate resistant mutations of Plasmodium falciparum dihydrofolate reductase selected in Escherichia coli.
Chusacultanachai S; Thiensathit P; Tarnchompoo B; Sirawaraporn W; Yuthavong Y
Mol Biochem Parasitol; 2002 Mar; 120(1):61-72. PubMed ID: 11849706
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study.
Biswas S; Escalante A; Chaiyaroj S; Angkasekwinai P; Lal AA
Trop Med Int Health; 2000 Oct; 5(10):737-43. PubMed ID: 11044269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]